FDA Inspection
Shilpa Pharma Lifesciences LimitedShilpa Pharma Lifesciences Limited – FDA Inspection, Jul 26, 2019
Record Details
This FDA Inspection record concerns Shilpa Pharma Lifesciences Limited, with an inspection on July 26, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 83adb497-fdf6-4c23-97c3-387b0f981a9a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099290
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shilpa Pharma Lifesciences Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 19, 2018 | Not classified | Office of Inspections and Investigations | |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shilpa Pharma Lifesciences Limited
- FDA Inspection 1268017 - 2025-03-14
- FDA Inspection 1122653 - 2020-02-07
- FDA Inspection 1038233 - 2018-01-19
- FDA Inspection 1004337 - 2016-12-16
- FDA Inspection 926998 - 2015-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.